109 related articles for article (PubMed ID: 3660405)
1. MC-838 (altiopril calcium): a novel orally active angiotensin converting enzyme inhibitor.
Sakai K; Aono J; Shiraki Y; Hinohara Y; Akamatsu A; Tanaka S; Kuromaru K
Tohoku J Exp Med; 1987 Aug; 152(4):363-74. PubMed ID: 3660405
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
[TBL] [Abstract][Full Text] [Related]
3. Contribution of the tissue angiotensin converting enzyme to the antihypertensive effect of altiopril calcium (MC-838) in spontaneously hypertensive rats.
Kamei K; Shiraki Y; Koga T; Sakai K
J Pharm Pharmacol; 1989 Apr; 41(4):279-80. PubMed ID: 2568474
[TBL] [Abstract][Full Text] [Related]
4. Comparative cardiovascular effects of a novel angiotensin converting enzyme inhibitor altiopril calcium (MC-838) and captopril in spontaneously hypertensive rats.
Akima M; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():223-36. PubMed ID: 3293543
[TBL] [Abstract][Full Text] [Related]
5. Tissue angiotensin-converting enzyme blockade by MC-838 (altiopril calcium) infused intravenously to miniature pigs: comparison with captopril.
Sakai K; Shiraki Y; Akima M; Imagawa J; Hinohara Y; Koga T; Ichihara T; Tohira Y
Arch Int Pharmacodyn Ther; 1988; 294():228-40. PubMed ID: 2852930
[TBL] [Abstract][Full Text] [Related]
6. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
DeForrest JM; Waldron TL; Harvey C; Scalese R; Hammerstone S; Powell JR; Karanewsky D
J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654
[TBL] [Abstract][Full Text] [Related]
7. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW
J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological studies on (4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino] propionyl]-2-oxo-imidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new ACE inhibitor: I. ACE inhibitory and anti-hypertensive activities.
Kubo M; Kato J; Ochiai T; Ishida R
Jpn J Pharmacol; 1990 Jun; 53(2):201-10. PubMed ID: 2200918
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
Friehe H; Ney P
Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiotensin converting enzyme by CV-3317, a non-sulfhydryl compound.
Inada Y; Terashita Z; Imura Y; Tanabe M; Nishikawa K; Kikuchi S
Jpn J Pharmacol; 1986 Sep; 42(1):99-108. PubMed ID: 3025487
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.
Lembeck F; Griesbacher T; Eckhardt M
Br J Pharmacol; 1990 May; 100(1):49-54. PubMed ID: 2164861
[TBL] [Abstract][Full Text] [Related]
13. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
[TBL] [Abstract][Full Text] [Related]
14. Chronotropic and inotropic effects of a new angiotensin converting enzyme inhibitor, MC-838 (altiopril calcium), on the dog heart.
Chiba S; Furukawa Y; Saegusa K; Ohba Y
Jpn Heart J; 1988 Nov; 29(6):841-8. PubMed ID: 3241337
[TBL] [Abstract][Full Text] [Related]
15. SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.
Rubin B; Laffan RJ; Kotler DG; O'Keefe EH; Demaio DA; Goldberg ME
J Pharmacol Exp Ther; 1978 Feb; 204(2):271-80. PubMed ID: 202692
[No Abstract] [Full Text] [Related]
16. A radioimmunoassay for MC-838 (altiopril calcium), a novel angiotensin-converting enzyme inhibitor.
Hinohara Y; Tanaka S; Wakabayashi K
J Pharmacobiodyn; 1988 Jun; 11(6):411-5. PubMed ID: 3171883
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effect of N-alpha-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline (MK-0521) on angiotensin converting enzyme in vitro].
Ino Y; Oda M; Sato T; Iwaki M
Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):219-24. PubMed ID: 2545578
[TBL] [Abstract][Full Text] [Related]
18. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Kajiwara Y; Iijima M; Kitabatake K
Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
[TBL] [Abstract][Full Text] [Related]
20. Captopril (SQ 14,225) (D-3-mercapto-2-methylpropranoyl-L-proline): a novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent.
Rubin B; Antonaccio MJ; Horovitz ZP
Prog Cardiovasc Dis; 1978; 21(3):183-94. PubMed ID: 214818
[No Abstract] [Full Text] [Related]
[Next] [New Search]
